IradiMed (IRMD) Director Monty K. Allen Sells 1,419 Shares

What Happened

• Monty K. Allen, a director of IradiMed Corp. (IRMD), sold a total of 1,419 shares in open-market transactions on September 3, 2026. The filings report two lots: 1,014 shares at a weighted average price of $86.44 for $87,650, and 405 shares at $86.35 for $34,972. Total proceeds were about $122,622 (overall weighted average ≈ $86.40). This was a sale of existing shares (not a purchase or option exercise).

Key Details

• Transaction date: 2026-09-03 (open-market sales, transaction code S).
• Reported lots: 1,014 shares @ $86.44 (proceeds $87,650); 405 shares @ $86.35 (proceeds $34,972). Total = 1,419 shares / ~$122,622.
• Footnote (F1): The trades were executed in multiple trades at prices ranging $86.36–$86.54; the filing reports a weighted average and the reporting person offers to provide detailed trade-level prices/quantities on request.
• Filing date: 2026-09-08 — appears to be filed after the typical two-business-day Form 4 deadline (i.e., likely one business day late).
• Shares owned after transaction: Not specified in the provided excerpt; see the full Form 4 for post-transaction holdings.
• No 10b5‑1 plan or special withholding/derivative activity was indicated in the excerpt.

Context

• This was a straightforward sale by a company director. Insider sales are often routine (for liquidity, diversification, tax reasons, etc.) and do not by themselves prove a change in view about the company. Purchases tend to be more informative about insider sentiment. Check the full Form 4 for holdings and any additional context before drawing conclusions.